BOOK A MEETING
We're excited to share the positive results from our study with Myota in reducing risk of developing Type 2 diabetes.
We're excited to share the positive results from our study with Myota in reducing risk of developing Type 2 diabetes.
Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials
Lindus Health aims to enhance the efficiency and success rates of CNS, neurology and psychiatric clinical trials with its "All-in-One CRO" offering to this market segment.
Lindus Health Launches “All-In-One Metabolic CRO” Offering to Accelerate and Enhance Metabolic Clinical Trials
Now available: Lindus Health's "All-In-One Metabolic CRO" to accelerate and streamline research in metabolic conditions such as diabetes, obesity, NASH, and more.
Running Effective DTx Studies in EU Markets, and Considerations for Cross Country Data Acceptance
As more innovators join the digital therapeutics (DTx) landscape, understanding the intricacies of running clinical trials in Europe becomes increasingly essential. Tune in to discover how CROs in the DTx space help sponsors navigate these hurdles to successfully conduct clinical trials, delivering essential digital health interventions to patients faster.
Lindus Health Introduces Bespoke “All-In-One CRO for Digital Therapeutics” Solution to Companies In the Space to Streamline Clinical Trials
We're introducing our All-In-One CRO solution for the digital therapeutics market.
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board
We are thrilled to announce Robert S. Langer, co-founder of Moderna, has joined our advisory board.
Being Nimble and Tech-Forward in Clinical Trial Operations
In our latest fireside chat, we sat down with Dan Gusz, Chief of Staff at Signos, to discuss some of the common challenges sponsors see when collaborating with CROs along with the benefits of being cutting-edge in technology when approaching clinical trials.